0001493152-24-022920.txt : 20240606 0001493152-24-022920.hdr.sgml : 20240606 20240606160107 ACCESSION NUMBER: 0001493152-24-022920 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 EFFECTIVENESS DATE: 20240606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-515360 FILM NUMBER: 241024928 BUSINESS ADDRESS: STREET 1: 55 GREENS FARMS ROAD CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: (203) 409-5444 MAIL ADDRESS: STREET 1: 55 GREENS FARMS ROAD CITY: WESTPORT STATE: CT ZIP: 06880 D 1 primary_doc.xml X0708 D LIVE 0001530766 BioSig Technologies, Inc. 55 GREENS FARMS ROAD 1ST FLOOR WESTPORT CT CONNECTICUT 06880 (203) 409-5444 DELAWARE None None Corporation true Anthony Amato 55 Greens Farms Road 1st Floor Westport CT CONNECTICUT 06880 Executive Officer Director Chief Executive Officer Frederick D. Hrkac 55 Greens Farms Road 1st Floor Westport CT CONNECTICUT 06880 Executive Officer Director Acting Chief Financial Officer Steven E. Abelman 55 Greens Farms Road 1st Floor Westport CT CONNECTICUT 06880 Director Donald F. Browne 55 Greens Farms Road 1st Floor Westport CT CONNECTICUT 06880 Director Chris Baer 55 Greens Farms Road 1st Floor Westport CT CONNECTICUT 06880 Director Other Health Care Decline to Disclose 06b false 2024-05-29 false true false 0 H.C. Wainwright & Co. 000000375 None None 430 Park Avenue New York NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS true 3000005 3000005 0 Represents total gross proceeds received by the company in connection with a registered direct offering of shares of common stock and a concurrent private placement of common stock purchase warrants. false 4 240000 true 0 H.C. Wainwright & Co. ("HCW") acted as exclusive placement agent for the offering. HCW received a cash fee equal to 7.0% of the gross proceeds of the offering and a management fee equal to 1.0% of the gross proceeds raised in the offering. 0 false BioSig Technologies, Inc. /s/ Anthony Amato Anthony Amato Chief Executive Officer 2024-06-06